Are Cheaper Ozempic Knockoffs Safe? | Big Take

Cheaper, knockoff versions of Ozempic, Wegovy and Zepbound are flooding the market, often promoted by telehealth companies in online ads and by influencers on TikTok and Instagram. These versions of the drugs are made by so-called compounding pharmacies, an obscure corner of America’s pharmaceutical market which makes drugs that aren’t approved by the Food and Drug Administration.
On today’s Big Take podcast, Bloomberg reporters Ike Swetlitz and Madison Muller tell host Sarah Holder about their investigation into a $1 billion shadow industry that could be putting Americans’ health in danger.
Read more: Unsafe Ozempic Knockoffs Are Flooding the Market (www.bloomberg....)
See omnystudio.com/listener (omnystudio.com...) for privacy information.
Each weekday, The Big Take brings you one story-one big, important story. Host Wes Kosova talks to Bloomberg journalists around the world, experts and the people at the center of the news to help you understand what’s happening, what it means and why it matters. Money, politics, the economy and business, energy, the environment, technology-we cover it all on The Big Take.
Subscribe to Bloomberg Podcasts: bit.ly/Bloombe...
Listen to more of The Big Take: • The Big Take | Bloombe...
#Bloomberg #Podcast #TheBigTake
Visit us: www.bloomberg....
Follow Bloomberg Podcasts on Twitter: / podcasts
Visit our other KZbin channels:
Bloomberg Television: / @markets
Bloomberg Originals: / bloomberg
Quicktake: / @bloombergquicktake
For coverage on news, markets and more: www.bloomberg.c...

[@cloakster]

Good segment. 👍